Clinical Trials Logo

Filter by:
NCT ID: NCT00285363 Withdrawn - Cancer Clinical Trials

Quality of Life Among Children and Adolescents With Cancer

Start date: March 2005
Phase:
Study type: Observational

This descriptive study aims to allow children and adolescents who have cancer to self-evaluate their quality of life. It is hypothesized that treatment affects quality of life in the areas of physical and social functioning. It is further hypothesized that these effects dissipate within 6 months after treatment is completed.

NCT ID: NCT00281255 Withdrawn - Clinical trials for Cardiovascular Diseases

Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy

Start date: June 2003
Phase: Phase 1/Phase 2
Study type: Interventional

This study will determine whether an acute infusion of intravenous allopurinol improves the inotropic response to dobutamine in patients with idiopathic dilated cardiomyopathy (DCM) as measured by cardiac magnetic resonance imaging (CMR).

NCT ID: NCT00279851 Withdrawn - Hypoglycemia Clinical Trials

Blood Sugars in Children With Idiopathic Seizures.

Start date: February 2006
Phase:
Study type: Observational

The purpose of this study is to determine if there is a significant percentage of children with the diagnosis of idiopathic seizures who have undiagnosed or unrecognized hypoglycemia (low blood sugar).

NCT ID: NCT00279461 Withdrawn - Clinical trials for Vitamin D Deficiency

Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis

Start date: May 2009
Phase: Phase 2
Study type: Interventional

Recent studies have demonstrated that subjects with low blood levels of vitamin D are at a higher risk of developing autoimmune diseases such as Rheumatoid Arthritis (RA). We are pursuing these studies to test the hypothesis that restoration of vitamin D levels ameliorates the manifestations of RA. We will test this hypothesis by inviting patients with RA to participate in a trial that examines the effects of oral vitamin D administration on the clinical expression of this disease. For this purpose, the participants of this trial will be asked to take an oral dose of 2,000 units of vitamin D daily for 6 months. We will examine the participant's joints, assess disease activity measures, and determine his/her blood levels of vitamin D before starting this treatment and periodically thereafter.

NCT ID: NCT00279266 Withdrawn - Diabetes Mellitus Clinical Trials

Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy

Start date: January 2006
Phase: N/A
Study type: Interventional

This study will examine the effect of oral thiamine (Vitamin B1) supplementation on pain in patients with diabetic peripheral neuropathy.

NCT ID: NCT00278616 Withdrawn - Clinical trials for ANTIPHOSPHOLIPID SYNDROME

Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome

Start date: August 2005
Phase: Phase 1
Study type: Interventional

Antiphospholipid syndrome is disease believed to be due to immune cells, cells which normally protect the body, but are now producing the protein which leads to abnormal clotting in the body. This study is designed to examine whether treating patients with high dose cyclophosphamide together with CAMPATH (drugs which reduce the function of the immune system), followed by return of the previously collected stem cells will result in improvement in the disease. Stem cells are undeveloped cells that have the capacity to grow into mature blood cells, which normally circulate in the blood stream. The purpose of the intense chemotherapy is to destroy the cells in the immune system which may be causing the disease. The purpose of the stem cell infusion is to produce a normal immune system that will no longer attack the body. The study purpose is to examine whether this treatment will result in improvement in the disease. The drugs used in this study treatment are drugs for commonly used for immune suppression.

NCT ID: NCT00278590 Withdrawn - Clinical trials for Systemic Lupus Erythematosus

Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus

Start date: July 2004
Phase: Phase 1
Study type: Interventional

This trial is designed to evaluate the safety of treating systemic lupus erythematosus participants with cyclophosphamide and CAMPATH-1H followed by allogeneic stem cell transplant. There will be no randomization in this study. All subjects who are determined to be eligible for the study treatment will receive cyclophosphamide and CAMPATH-1H followed by allogeneic stem cell transplant. The purpose of the intense chemotherapy is to destroy the cells in the immune system which may be causing this disease. The purpose of the stem cell infusion is to produce a normal immune system that will no longer attack body. The study purpose is to examine whether this treatment will result in improvement in the lupus disease.

NCT ID: NCT00277966 Withdrawn - Clinical trials for Congenital Disorders

Cath Lab Performance Improvement

Start date: January 2004
Phase: N/A
Study type: Observational

In 2004, the Cardiac Cath Lab at Children's Healthcare of Atlanta was asked to conduct a Quality Improvement Review examining radiation exposure.

NCT ID: NCT00277420 Withdrawn - Overweight Clinical Trials

Trial of a Culturally-Appropriate Weight Loss Intervention for Overweight Latino Children

Start date: August 2005
Phase: N/A
Study type: Interventional

This project aims to conduct a unique, community-based intervention consisting of a randomized trial of a culturally-appropriate weight loss intervention for overweight Latino children in Milwaukee. The intervention promotes lifestyle changes through a low weight loss regimen, one or more physical activities ranging from soccer to hip-hop dance, and dietary counseling including cooking classes for parents. In addition to weight reduction for overweight Latino children, the project has the potential to reduce missed school days and improve self-esteem and quality of life.

NCT ID: NCT00276146 Withdrawn - Anemia, Sickle Cell Clinical Trials

Dipyridamole/Magnesium To Improve Sickle Cell Hydration

Start date: May 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the benefits as well as side effects of giving drugs called dipyridamole and magnesium to patients with sickle cell anemia (SCA).